Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €170.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 11:05 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

l'oreal- new (ORNV) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/28/15 - €171.65
52 Week Low
04/30/15 - €166.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for L'OREAL- NEW (ORNV)

l'oreal- new (ORNV) Related Bloomberg News

View More Bloomberg News

l'oreal- new (ORNV) Details

L’Oréal S.A. creates and develops various cosmetics products for women and men worldwide. It provides various products, such as hair care, hair color, skin care, make-up, perfumes, and dermocosmetic products, as well as operates body shops that provide cosmetics and toiletry products. The company offers its products under the L’oréal Professionnel, Red Ken, Kérastase, Matrix, L’Oréal Paris, Garnier, Maybelline, Softsheen Carson, Essie, Lancôme, Giorgio Armani, Yves Saint Laurent, Biotherm, Kiehl’s, Ralph Lauren, Shu Uemura, Cacharel, Helena Rubinstein, Diesel, Clarisonic, Viktor & Rolf, Urban Decay, Vichy, La Roche Posay, SkinCeuticals, Innéov, Sanoflore, and Roger & Gallet brand names. L’Oréal S.A. sells its products to hair salons, hypermarkets, supermarkets, drugstores, traditional stores, department stores, perfumeries, travel retail outlets, pharmacies, drugstores, and medispas, as well as through e-commerce Websites. The company was founded in 1909 and is headquartered in Clichy, France.

78,611 Employees
Last Reported Date: 03/18/15
Founded in 1909

l'oreal- new (ORNV) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: €3.9M
Compensation as of Fiscal Year 2013.

l'oreal- new (ORNV) Key Developments

L'Oreal SA Appoints Sophie Bellon as New Director; Approves Dividend for the Year 2014, Payable on May 7, 2015

L'Oreal SA announced that at its AGM held on April 22, 2015, the company appointed a new director, Mrs. Sophie Bellon, for a period of 4 years. The company also decided on the payment of a dividend of EUR 2.70 per share. This dividend is increased to EUR 2.97 for shares held in registered form continuously for at least 2 years. Dividend payment date is May 7th, 2015.

L'Oreal SA - Pre Recorded Shareholder/Analyst Call


L'Oreal SA Announces Sales Results for the First Quarter 2015

L'Oreal SA announced sales results for the first quarter 2015. For the quarter, the company’s sales were EUR 6.44 billion.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORNV:FP €170.00 EUR 0.00

ORNV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bristol-Myers Squibb Co $64.95 USD -0.37
Danone SA €63.68 EUR -1.29
eBay Inc $58.38 USD -0.73
LVMH Moet Hennessy Louis Vuitton SE €154.65 EUR -4.85
Mondelez International Inc $38.21 USD -0.41
View Industry Companies

Industry Analysis


Industry Average

Valuation ORNV Industry Range
Price/Earnings 33.4x
Price/Sales 3.9x
Price/Book 4.3x
Price/Cash Flow 18.0x
TEV/Sales 3.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact L'OREAL- NEW, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at